Recommendations on the use of azole antifungals in hematology-oncology patients

por Azanza, José Ramón, Mensa, José, Barberán, José, Vázquez, Lourdes, de Oteyza, Jaime Pérez, Kwon, Mi, Yáñez, Lucrecia, Aguado, José María, Gracian, Antonio Cubillo, Solano, Carlos, Camps, Isabel Ruiz, Fortún, Jesús, Lletí, Miguel Salavert, Gudiol, Carlota, Rubio, Teresa Olave, García-Vidal, Carolina, Tarrats, Montserrat Rovira, Grande, María Suárez-Lledó, González-Sierra, Pedro, Gutiérrez, Carlos Dueñas
Publicado 2023

Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659...

por Gordon, Leo I., Karmali, Reem, Kaplan, Jason B., Popat, Rakesh, Burris, Howard A., Ferrari, Silvia, Madan, Sumit, Patel, Manish R., Gritti, Giuseppe, El-Sharkawi, Dima, Chau, F. Ian, Radford, John, de Oteyza, Jaime Pérez, Zinzani, Pier Luigi, Iyer, Swaminathan P., Townsend, William, Miao, Harry, Proscurshim, Igor, Wang, Shining, Katyayan, Shilpi, Yuan, Ying, Zhu, Jiaxi, Stumpo, Kate, Shou, Yaping, Carpio, Cecilia, Bosch, Francesc
Publicado 2023

Predicting long-term disease control in transplant-ineligible patients with multiple myeloma: impact of an MGUS-like signature

por Rodríguez-Otero, Paula, Mateos, María Victoria, Martínez-López, Joaquín, Hernández, Miguel-Teodoro, Ocio, Enrique M., Rosiñol, Laura, Martínez, Rafael, Teruel, Ana-Isabel, Gutiérrez, Norma C., Bargay, Joan, Bengoechea, Enrique, González, Yolanda, de Oteyza, Jaime Pérez, Gironella, Mercedes, Nuñez-Córdoba, Jorge M., Encinas, Cristina, Martín, Jesús, Cabrera, Carmen, Palomera, Luis, de Arriba, Felipe, Cedena, María Teresa, Puig, Noemí, Oriol, Albert, Paiva, Bruno, Bladé, Joan, Lahuerta, Juan José, San Miguel, Jesús F.
Publicado 2019

Differences in ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia

por Megías-Vericat, Juan Eduardo, Martínez-Cuadrón, David, López, Joaquín Martínez, Bergua, Juan Miguel, Tormo, Mar, Serrano, Josefina, González, Ataulfo, de Oteyza, Jaime Pérez, Vives, Susana, Vidriales, Belén, Herrera, Pilar, Vera, Juan Antonio, Martínez, Aurelio López, de la Fuente, Adolfo, Amador, Ma Lourdes, Hernández-Rivas, José-Ángel, Fernández, Ma Ángeles, Cerveró, Carlos Javier, Morillo, Daniel, Campo, Pilar Hernández, Gorrochategui, Julián, Primo, Daniel, Rojas, José Luis, Guenova, Margarita, Ballesteros, Joan, Sanz, Miguel, Montesinos, Pau
Publicado 2019

Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM)

por González-Rincón, Julia, Garcia-Vela, José A., Gómez, Sagrario, Fernández-Cuevas, Belén, Nova-Gurumeta, Sara, Pérez-Sanz, Nuria, Alcoceba, Miguel, González, Marcos, Anguita, Eduardo, López-Jiménez, Javier, González-Barca, Eva, Yáñez, Lucrecia, Pérez-Persona, Ernesto, de la Serna, Javier, Fernández-Zarzoso, Miguel, Deben, Guillermo, Peñalver, Francisco J., Fernández, María C., de Oteyza, Jaime Pérez, Andreu, M. Ángeles, Ruíz-Guinaldo, M. Ángeles, Paz-Arias, Raquel, García-Malo, M. Dolores, Recasens, Valle, Collado, Rosa, Córdoba, Raúl, Navarro-Matilla, Belén, Sánchez-Beato, Margarita, García-Marco, José A.
Publicado 2021

High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and...

por García-Marco, José A., Jiménez, Javier López, Recasens, Valle, Zarzoso, Miguel Fernández, González-Barca, Eva, De Marcos, Nieves Somolinos, Ramírez, M. Jose, Parraga, Francisco Javier Peñalver, Yañez, Lucrecia, De La Serna Torroba, Javier, Malo, Maria Dolores Garcia, Ariznavarreta, Guillermo Deben, Persona, Ernesto Perez, Guinaldo, M. Angeles Ruiz, De Paz Arias, Raquel, Llanos, Elena Bañas, Jarque, Isidro, Valle, M. del Carmen Fernandez, Tatay, Ana Carral, De Oteyza, Jaime Perez, Martin, Eva Maria Donato, Fernández, Inmaculada Perez, Martinez, Rafael Martinez, Costa, M. Angeles Andreu, Champ, Diana, Suarez, Julio García, Díaz, Marcos González, Ferrer, Secundino, Carbonell, Félix, García-Vela, José A.
Publicado 2019

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms

por Steensma, David P., Wermke, Martin, Klimek, Virginia M., Greenberg, Peter L., Font, Patricia, Komrokji, Rami S., Yang, Jay, Brunner, Andrew M., Carraway, Hetty E., Ades, Lionel, Al-Kali, Aref, Alonso-Dominguez, Juan M., Alfonso-Piérola, Ana, Coombs, Catherine C., Deeg, H. Joachim, Flinn, Ian, Foran, James M., Garcia-Manero, Guillermo, Maris, Michael B., McMasters, Malgorzata, Micol, Jean-Baptiste, De Oteyza, Jaime Perez, Thol, Felicitas, Wang, Eunice S., Watts, Justin M., Taylor, Justin, Stone, Richard, Gourineni, Vikram, Marino, Alyssa J., Yao, Huilan, Destenaves, Benoit, Yuan, Xiaobin, Yu, Kun, Dar, Sara, Ohanjanian, Lernik, Kuida, Keisuke, Xiao, Jianjun, Scholz, Catherine, Gualberto, Antonio, Platzbecker, Uwe
Publicado 2021